Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCPA Seeks To Push PBM Transparency With Momentum From Health Reform

This article was originally published in The Pink Sheet Daily

Executive Summary

Community pharmacy group lobbies for more co-sponsors for a recently introduced bill to expand upon reform's transparency provisions.

You may also be interested in...



Welcome Back, Coster: NCPA Forms Advocacy Center As Government Affairs VP Returns

John Coster will oversee all of the National Community Pharmacists Association's advocacy functions when he rejoins the group in May.

Welcome Back, Coster: NCPA Forms Advocacy Center As Government Affairs VP Returns

John Coster will oversee all of the National Community Pharmacists Association's advocacy functions when he rejoins the group in May.

Walgreens Pulls 7,500 Pharmacies Out Of Play For Future Network Contracts With CVS Caremark

Walgreens cites drug plan designs, lack of information and reimbursement rates in saying it will not participate in new or renewed prescription drug plan contracts with the PBM.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel